EMPLOYEE STOCK PLANS

The Home Depot, Inc. Amended and Restated 2005 Omnibus Stock Incentive Plan ("2005 Plan") and The Home Depot, Inc. 1997 Omnibus Stock Incentive Plan ("1997 Plan" and collectively with the 2005 Plan, the "Plans") provide that incentive and non-qualified stock options, stock appreciation rights, restricted stock, performance shares, performance units and deferred shares may be issued to selected associates, officers and directors of the Company. Under the 2005 Plan, the maximum number of shares of the Company’s common stock authorized for issuance is 255 million shares, with any award other than a stock option or stock appreciation right reducing the number of shares available for issuance by 2.11 shares. As of January 29, 2017, there were 133 million shares available for future grants under the 2005 Plan. No additional equity awards could be issued from the 1997 Plan after the adoption of the 2005 Plan on May 26, 2005.

Under the terms of the Plans, incentive stock options and non-qualified stock options must have an exercise price at or above the fair market value of the Company’s stock on the date of the grant. Typically, incentive stock options and non-qualified stock options vest at the rate of 25% per year commencing on the first or second anniversary date of the grant and expire on the tenth anniversary date of the grant. Additionally, certain stock options may become non-forfeitable upon the associate reaching age 60, provided the associate has had five years of continuous service. The Company recognized $26 million, $26 million and $23 million of stock-based compensation expense in fiscal 2016, 2015 and 2014, respectively, related to stock options.

Restrictions on the restricted stock issued under the Plans generally lapse according to one of the following schedules: (1) the restrictions on the restricted stock lapse over various periods up to five years, (2) the restrictions on 25% of the restricted stock lapse upon the third and sixth anniversaries of the date of issuance with the remaining 50% of the restricted stock lapsing upon the associate’s attainment of age 62, or (3) the restrictions on 25% of the restricted stock lapse upon the third and sixth anniversaries of the date of issuance with the remaining 50% of the restricted stock lapsing upon the earlier of the associate’s attainment of age 60 or the tenth anniversary of the grant date. The Company has also granted performance shares under the Plans, the payout of which is dependent on the Company’s performance against target average return on invested capital and operating profit over a three-year performance cycle. Additionally, certain awards may become non-forfeitable upon the associate’s attainment of age 60, provided the associate has had five years of continuous service. The fair value of the restricted stock and performance shares is expensed over the period during which the restrictions lapse. The Company recorded stock-based compensation expense related to restricted stock and performance shares of $199 million, $180 million and $168 million in fiscal 2016, 2015 and 2014, respectively.

In fiscal 2016, 2015 and 2014, there were an aggregate of 139 thousand, 152 thousand and 206 thousand deferred shares, respectively, granted under the Plans. For associates, each deferred share entitles the individual to one share of common stock to be received up to five years after the grant date of the deferred shares, subject to certain deferral rights of the associate. Additionally, certain awards may become non-forfeitable upon the associate reaching age 60, provided the associate has had five years of continuous service. The Company recorded stock-based compensation expense related to deferred shares of $16 million, $15 million and $14 million in fiscal 2016, 2015 and 2014, respectively.

The Company maintains two Employee Stock Purchase Plans ("ESPPs") (U.S. and non-U.S. plans). The plan for U.S. associates is a tax-qualified plan under Section 423 of the Internal Revenue Code. The non-U.S. plan is not a Section 423 plan. As of January 29, 2017, there were 21 million shares available under the plan for U.S associates and 19 million shares available under the non-U.S. plan. The purchase price of shares under the ESPPs is equal to 85% of the stock’s fair market value on the last day of the purchase period, which is a six-month period ending on December 31 and June 30 of each year. During fiscal 2016, there were 1 million shares purchased under the ESPPs at an average price of $111.14. Under the outstanding ESPPs as of January 29, 2017, employees have contributed $15 million to purchase shares at 85% of the stock’s fair market value on the last day (June 30, 2017) of the current purchase period. The Company recognized $26 million, $23 million and $20 million of stock-based compensation expense in fiscal 2016, 2015 and 2014, respectively, related to the ESPPs.

In total, the Company recorded stock-based compensation expense, including the expense of stock options, restricted stock, performance shares, deferred shares and ESPP shares, of $267 million, $244 million and $225 million, in fiscal 2016, 2015 and 2014, respectively.

The following table summarizes stock options outstanding at January 29, 2017 and changes during fiscal 2016 (shares in thousands):



	Number of Shares		Weighted Average Exercise Price
Outstanding at January 31, 2016	9,466		$	59.97
Granted	1,121		130.10
Exercised	(1,616	)	44.94
Canceled	(251	)	97.32
Outstanding at January 29, 2017	8,720		$	70.69

The total intrinsic value of stock options exercised was $140 million, $206 million and $234 million in fiscal 2016, 2015 and 2014, respectively. As of January 29, 2017, there were approximately 9 million stock options outstanding with a weighted average remaining life of six years and an intrinsic value of $590 million. As of January 29, 2017, there were approximately 4 million stock options exercisable with a weighted average exercise price of $43.68, a weighted average remaining life of four years, and an intrinsic value of $407 million. As of January 29, 2017, there were approximately 7 million stock options vested or expected to ultimately vest. As of January 29, 2017, there was $30 million of unamortized stock-based compensation expense related to stock options, which is expected to be recognized over a weighted average period of two years.

The following table summarizes restricted stock and performance shares outstanding at January 29, 2017 and changes during fiscal 2016 (shares in thousands):



	Number of Shares		Weighted Average Grant Date Fair Value
Outstanding at January 31, 2016	6,687		$	80.90
Granted	1,942		126.91
Restrictions lapsed	(2,727	)	65.56
Canceled	(450	)	99.81
Outstanding at January 29, 2017	5,452		$	103.41

As of January 29, 2017, there was $327 million of unamortized stock-based compensation expense related to restricted stock and performance shares, which is expected to be recognized over a weighted average period of two years. The total fair value of restricted stock and performance shares vesting during fiscal 2016, 2015 and 2014 was $354 million, $382 million and $334 million, respectively.